ProCE Banner Activity

Global Conference Coverage: Application and Implications of High-Impact Data From the European Hematology Association Congress 2022

Slideset Download
Download this summary slideset covering high-impact data for key studies in hematologic cancers as presented at the 2022 EHA annual meeting.

Released: June 30, 2022

Expiration: June 29, 2023

No longer available for credit.

Share

Faculty

Jesus San-Miguel

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Alessandra Tedeschi

Alessandra Tedeschi, MD

Consultant in Hematology
Department of Hematology
ASST GOM Niguarda
Milano, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Jazz Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Jesús F. San-Miguel, MD, PhD: consulting fees: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Karyopharm, Merck Sharpe & Dohme, Novartis, Regeneron, Roche, Sanofi, SecuraBio, Takeda.

Alessandra Tedeschi, MD

Consultant in Hematology
Department of Hematology
ASST GOM Niguarda
Milano, Italy

Alessandra Tedeschi, MD: consulting fees: AbbVie, AstraZeneca, BeiGene, Janssen.